Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
Clinical trial NCT01425749 · COMPLETED
Trial details
- NCT number
- NCT01425749
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.